The referral procedure started on 21 October 2004 The CHMP having considered the Rapporteur and the Co-Rapporteur assessment reports, and scientific discussion within the Committee was of the opinion that the benefit/ risk ratio of Calcium Sandoz Effervescent tablets, 500/ 1000 mg and associated names is considered to be favourable.
νόϊορπ όκιτυεκαµραφ οτ αιγ ΠΧΠ νώκινθε νωτ ησινόµρανε νητ όποκσ εµ ΚΕ ςητ ορθρά οτ εµ ανωφµύσ όκιτπµεπαραπ ΑΕΜ Ε νοτσ ελαβέπυ